Veeva Systems Inc.
NYSE:VEEVMedical - Healthcare Information Services
-$2.83 today
- Market cap
- $44.88B
- Beta
- 0.95
- P/E (TTM)
- 26.4
- EPS (TTM)
- $5.76
Volume 2.74M
Average 3.01M
VEEV Deferred Revenue
Payments received for goods or services the company will deliver within the next year.
Veeva Systems Inc.NYSE: VEEV
Deferred Revenue · Q2 FY2027 · quarter ended Jul 2026
Deferred revenue rises 18.3% from a year ago
Deferred revenue stood at $1.31B at the end of Q2 FY2027, up 18.3% from a year earlier and down 11.2% from the prior quarter. Over 3 fiscal years it compounded at +19.6% a year.
Context
- Deferred revenue amounted to 14.5% of total assets at the end of Q2 FY2027, up 0.6 pp from a year earlier.
- Deferred revenue increased in 3 of the last 3 fiscal years.
- FY2026 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether deferred revenue keeps rising in the next quarterly balance sheet after a +18.3% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Deferred Revenue history
USD · from the balance sheet
- Latest · FY2026
- 1.49B USD
- Year-over-year change
- +16.9%
- 4-year CAGR
- +19.4%
| Period | Period end | Deferred Revenue | YoY change |
|---|---|---|---|
| FY2026 | 2026-01-31 | 1.49B | +16.9% |
| FY2025 | 2025-01-31 | 1.27B | +21.4% |
| FY2024 | 2024-01-31 | 1.05B | +20.8% |
| FY2023 | 2023-01-31 | 869.29M | +18.8% |
| FY2022 | 2022-01-31 | 731.75M | — |
Deferred Revenue vs competitors
How VEEV compares with its peers on the latest reported figures
- VEEV's Jul 2026 deferred revenue of $1.31B is the 2nd highest of the 5 companies compared; the peer median is $103.31M.
- Its year-over-year change of +18.3% is the 2nd highest of 5, against a peer median of +5.9%.
- Deferred revenue amounts to 14.5% of total assets for VEEV, versus a peer median of 12.6%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Jun 2026 | $2.28B | +7.4% | +5.6% | 7.6% | |
| Jul 2026 | $1.31B | +18.3% | +19.6% | 14.5% | |
| Mar 2026 | $106.4M | +4.3% | +3.6% | 20.2% | |
| Sep 2026 | $100.23M | +0.2% | +0.3% | 9.2% | |
| Sep 2026 | $97.67M | +18.7% | +24.9% | 16.0% | |
| Peer median (excluding VEEV) | $103.31M | +5.9% | +4.6% | 12.6% | |
Competitors are the stored peer set for VEEV. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2022 Jan 2022 | FY2023 Jan 2023 | FY2024 Jan 2024 | FY2025 Jan 2025 | FY2026 Jan 2026 |
|---|---|---|---|---|---|
| Cash & Equivalents | 1.14B | 886.47M | 703.49M | 1.12B | 1.42B |
| Short-term Investments | 1.24B | 2.22B | 3.32B | 4.03B | 5.14B |
| Net Receivables | 694.4M | 785.23M | 888.54M | 1.06B | 1.31B |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | 0 | 81.46M | 86.92M | 101.46M | 126.47M |
| Total Current Assets | 3.11B | 3.97B | 5B | 6.31B | 8B |
| Property, Plant & Equipment (Net) | 104.14M | 105.15M | 104.13M | 119.78M | 145.89M |
| Goodwill | 439.88M | 439.88M | 439.88M | 439.88M | 439.88M |
| Intangible Assets | 101.94M | 82.48M | 63.02M | 44.46M | 30.31M |
| Long-term Investments | 0 | 0 | 0 | 0 | 0 |
| Tax Assets | 5.1M | 136.7M | 233.46M | 343.92M | 273.42M |
| Other Non-current Assets | 58.23M | 70.78M | 67.22M | 82.92M | 92.22M |
| Total Non-current Assets | 709.28M | 834.98M | 907.71M | 1.03B | 981.71M |
| Total Assets | 3.82B | 4.8B | 5.91B | 7.34B | 8.98B |
| Account Payables | 20.35M | 41.68M | 31.51M | 30.45M | 37.64M |
| Short-term Debt | 0 | 0 | 0 | 0 | 0 |
| Tax Payables | 7.76M | 4.95M | 19.49M | 9.02M | 6.7M |
| Deferred Revenue | 731.75M | 869.29M | 1.05B | 1.27B | 1.49B |
| Other Current Liabilities | 15.79M | 16.81M | 19.76M | 18.8M | 45.86M |
| Total Current Liabilities | 840.78M | 1.01B | 1.18B | 1.4B | 1.64B |
| Long-term Debt | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 2.22M | 1.49M | 2.05M | 587K | 558K |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 18.23M | 30.08M | 38.72M | 42.59M | 43.27M |
| Total Non-current Liabilities | 64.05M | 81.24M | 87.21M | 108.98M | 127.54M |
| Total Liabilities | 904.83M | 1.09B | 1.27B | 1.51B | 1.76B |
| Common Stock | 2K | 2K | 2K | 2K | 2K |
| Retained Earnings | 1.73B | 2.21B | 2.74B | 3.45B | 4.36B |
| Accumulated OCI | (11.96M) | (31.13M) | (10.64M) | (8.42M) | 8.16M |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 2.91B | 3.72B | 4.64B | 5.83B | 7.21B |
| Total Debt | 54.59M | 60.98M | 55.78M | 75.78M | 95.86M |
| Net Debt | (1.08B) | (825.49M) | (647.71M) | (1.04B) | (1.33B) |
Veeva Systems Inc.
NYSE:VEEV
Intrinsic Alpha fair value
Locked
Current Price
$277.20
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.